147 related articles for article (PubMed ID: 12968033)
1. Two carboxyl-terminal activation regions of Epstein-Barr virus latent membrane protein 1 activate NF-kappaB through distinct signaling pathways in fibroblast cell lines.
Saito N; Courtois G; Chiba A; Yamamoto N; Nitta T; Hironaka N; Rowe M; Yamamoto N; Yamaoka S
J Biol Chem; 2003 Nov; 278(47):46565-75. PubMed ID: 12968033
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2.
Eliopoulos AG; Blake SM; Floettmann JE; Rowe M; Young LS
J Virol; 1999 Feb; 73(2):1023-35. PubMed ID: 9882303
[TBL] [Abstract][Full Text] [Related]
3. The C-terminal activating region 2 of the Epstein-Barr virus-encoded latent membrane protein 1 activates NF-kappaB through TRAF6 and TAK1.
Wu L; Nakano H; Wu Z
J Biol Chem; 2006 Jan; 281(4):2162-9. PubMed ID: 16280329
[TBL] [Abstract][Full Text] [Related]
4. Roles of TRAF2 and TRAF3 in Epstein-Barr virus latent membrane protein 1-induced alternative NF-kappaB activation.
Song YJ; Kang MS
Virus Genes; 2010 Oct; 41(2):174-80. PubMed ID: 20585848
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus latent membrane protein 1 modulates distinctive NF- kappaB pathways through C-terminus-activating region 1 to regulate epidermal growth factor receptor expression.
Kung CP; Raab-Traub N
J Virol; 2010 Jul; 84(13):6605-14. PubMed ID: 20410275
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation.
Luftig M; Yasui T; Soni V; Kang MS; Jacobson N; Cahir-McFarland E; Seed B; Kieff E
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):141-6. PubMed ID: 14691250
[TBL] [Abstract][Full Text] [Related]
7. Changes in expression induced by Epstein-Barr Virus LMP1-CTAR1: potential role of bcl3.
Edwards RH; Marquitz AR; Raab-Traub N
mBio; 2015 Apr; 6(2):. PubMed ID: 25873381
[TBL] [Abstract][Full Text] [Related]
8. Unique signaling properties of CTAR1 in LMP1-mediated transformation.
Mainou BA; Everly DN; Raab-Traub N
J Virol; 2007 Sep; 81(18):9680-92. PubMed ID: 17626074
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K.
Mainou BA; Everly DN; Raab-Traub N
Oncogene; 2005 Oct; 24(46):6917-24. PubMed ID: 16007144
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr latent membrane protein 1 transformation site 2 activates NF-kappaB in the absence of NF-kappaB essential modifier residues 133-224 or 373-419.
Boehm D; Gewurz BE; Kieff E; Cahir-McFarland E
Proc Natl Acad Sci U S A; 2010 Oct; 107(42):18103-8. PubMed ID: 20923877
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor through effects on Bcl-3 and STAT3.
Kung CP; Raab-Traub N
J Virol; 2008 Jun; 82(11):5486-93. PubMed ID: 18367518
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus latent membrane protein-1 (LMP1) signalling is distinct from CD40 and involves physical cooperation of its two C-terminus functional regions.
Floettmann JE; Eliopoulos AG; Jones M; Young LS; Rowe M
Oncogene; 1998 Nov; 17(18):2383-92. PubMed ID: 9811470
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-kappaB2 to p52 via an IKKgamma/NEMO-independent signalling pathway.
Eliopoulos AG; Caamano JH; Flavell J; Reynolds GM; Murray PG; Poyet JL; Young LS
Oncogene; 2003 Oct; 22(48):7557-69. PubMed ID: 14576817
[TBL] [Abstract][Full Text] [Related]
14. Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1).
Eliopoulos AG; Young LS
Oncogene; 1998 Apr; 16(13):1731-42. PubMed ID: 9582021
[TBL] [Abstract][Full Text] [Related]
15. Induction of epidermal growth factor receptor expression by Epstein-Barr virus latent membrane protein 1 C-terminal-activating region 1 is mediated by NF-kappaB p50 homodimer/Bcl-3 complexes.
Thornburg NJ; Raab-Traub N
J Virol; 2007 Dec; 81(23):12954-61. PubMed ID: 17881446
[TBL] [Abstract][Full Text] [Related]
16. LMP1 TRAFficking activates growth and survival pathways.
Soni V; Cahir-McFarland E; Kieff E
Adv Exp Med Biol; 2007; 597():173-87. PubMed ID: 17633026
[TBL] [Abstract][Full Text] [Related]
17. BS69 cooperates with TRAF3 in the regulation of Epstein-Barr virus-derived LMP1/CTAR1-induced NF-kappaB activation.
Ikeda O; Miyasaka Y; Yoshida R; Mizushima A; Oritani K; Sekine Y; Kuroda M; Yasui T; Fujimuro M; Muromoto R; Nanbo A; Matsuda T
FEBS Lett; 2010 Mar; 584(5):865-72. PubMed ID: 20138174
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-kappaB through a pathway that includes the NF-kappaB-inducing kinase and the IkappaB kinases IKKalpha and IKKbeta.
Sylla BS; Hung SC; Davidson DM; Hatzivassiliou E; Malinin NL; Wallach D; Gilmore TD; Kieff E; Mosialos G
Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10106-11. PubMed ID: 9707608
[TBL] [Abstract][Full Text] [Related]
19. Latent membrane protein 1 of Epstein-Barr virus stimulates processing of NF-kappa B2 p100 to p52.
Atkinson PG; Coope HJ; Rowe M; Ley SC
J Biol Chem; 2003 Dec; 278(51):51134-42. PubMed ID: 14532284
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus latent membrane protein-1 (LMP1) C-terminus activation region 2 (CTAR2) maps to the far C-terminus and requires oligomerisation for NF-kappaB activation.
Floettmann JE; Rowe M
Oncogene; 1997 Oct; 15(15):1851-8. PubMed ID: 9362452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]